Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
73 studies found for:    Northwestern AND Hepatitis
Show Display Options
Rank Status Study
1 Terminated Prediction of Hepatitis C Recurrence in Liver Transplant Recipients
Conditions: Complication of Transplanted Liver;   Hepatitis C, Chronic
2 Recruiting Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
Conditions: Liver Transplant;   Hepatitis C;   Chronic Kidney Disease;   Acute Rejection
3 Not yet recruiting Chronic Hepatitis B and C Recall Northern Holland
Conditions: Hepatitis B;   Hepatitis C
4 Recruiting Cameroon Baptist Convention Health Board Chronic Hepatitis B Cohort Study
Conditions: Hepatitis B;   Hepatitis B, Chronic
5 Completed Optimizing Kidney Transplant Informed Consent
Condition: End-stage Kidney Disease
Intervention: Behavioral: Inform Me: web-based education tool
6 Withdrawn Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIV
Conditions: HIV Infections;   Hepatitis B
Interventions: Drug: Telbivudine;   Drug: Lamivudine;   Drug: Efavirenz;   Drug: Didanosine;   Drug: Abacavir
7 Active, not recruiting Way to Cure: Developing Effective Strategies to Promote Adherence to Hepatitis C Therapy Among Older Adults
Condition: Hepatitis C
Intervention: Other: GlowCap
8 Completed LCP-Tacro vs. Azathioprine for the Treatment of Autoimmune Hepatitis
Condition: Autoimmune Hepatitis
Interventions: Drug: LCP-Tacro (tacrolimus);   Drug: Azathioprine
9 Completed Short Duration Combination Therapy With Daclatasvir, Asunaprevir, BMS-791325 and Sofosbuvir in Subjects Infected With Chronic Hepatitis-C (FOURward Study)
Condition: Hepatitis C
Interventions: Drug: DCV/ASV/BMS-791325;   Drug: Ribavirin;   Drug: Sofosbuvir;   Drug: Peginterferon α-2a
10 Recruiting Study of Oral Treatments for Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: sofosbuvir/ledipasvir;   Drug: ombitasvir/paritaprevir/ritonavir (Phase 1 only);   Drug: elbasvir/grazoprevir;   Drug: Dasabuvir
11 Completed Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment Naive
Condition: Chronic Hepatitis C
Interventions: Drug: Viramidine;   Drug: Ribavirin;   Drug: pegylated interferon alfa-2a
12 Completed
Has Results
Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection
Condition: Hepatitis B, Chronic
Intervention: Drug: entecavir
13 Completed Safety and Effectiveness of an Adjuvant in Improving Immune Response to Hepatitis B Virus Vaccine in HIV Infected Individuals
Condition: HIV Infections
Interventions: Biological: Hepatitis B virus vaccine with GM-CSF adjuvant;   Biological: Hepatitis B virus vaccine
14 Enrolling by invitation Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection
Condition: Chronic Hepatitis B
Interventions: Drug: GS-4774;   Drug: GS-9620;   Drug: Tenofovir disoproxil fumarate (TDF)
15 Enrolling by invitation A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection
Condition: Hepatitis C Virus Infection
Intervention: Drug: Sofosbuvir
16 Recruiting HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network
Condition: Hepatitis C
17 Recruiting An Observational Study of Hepatitis C Virus in Pregnancy
Condition: Hepatitis C
18 Completed
Has Results
Study Comparing Daclatasvir (BMS-790052) With Telaprevir Combined With Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Virus Infection
Condition: Hepatitis C
Interventions: Drug: Daclatasvir;   Drug: Telaprevir;   Drug: Peginterferon alfa-2a;   Drug: Ribavirin
19 Completed Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection
Condition: Hepatitis C, Chronic
Intervention: Drug: PEGylated recombinant interleukin 29 (PEG-rIL-29)
20 Completed
Has Results
Pre-Transplant Treatment to Prevent Recurrence of Hepatitis C After Liver Transplantation
Condition: Hepatitis C
Intervention: Drug: LADR Treatment

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.